Gelonghui, December 27丨Huisheng Biotech (300871.SZ) announced the 2023 employee shareholding plan (draft). The total amount of capital to be raised in the employee shareholding plan is not more than RMB 16.7385 million. Using “shares” as the subscription unit, each share is 1.00 yuan. The maximum number of shares in the employee shareholding plan is 16.7385 million shares.
After review and approval by the company's shareholders' meeting, the employee's shareholding plan will use 10 yuan/share to repurchase the shares already repurchased by the company's special securities account.
Participants in this employee stock ownership plan are company directors (excluding independent directors), supervisors, senior management, middle management of the company (including subsidiaries), core business (technical) personnel, and other employees deemed by the board of directors to be motivated. The total number of participants in this employee stock ownership plan is not more than 92, including 8 directors (excluding independent directors), supervisors, and senior management. The exact number of participants is determined based on the actual payment status of employees.
The employee's shareholding plan lasts no more than 48 months, calculated from the date the company announced the last transfer of the underlying stock to the employee's shareholding plan.